Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
4D Molecular Therapeutics
Business Segments
Products & Services
Research And Development Expense Excluding Acquired In Process Cost
Research And Development Expense Excluding Acquired In Process Cost
4D Molecular Therapeutics
·
Products & Services
·
1 segment
·
Rolls up to
R&D
Breakdown
Segments
Four D To One Five Zero
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q1 '26
Four D To One Five Zero
$42.68M
Total
$64.98M